ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,612 | -13.4% | 115 | 0.0% | 0.00% | – |
Q4 2022 | $5,328 | +6.6% | 115 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | -28.6% | 115 | 0.0% | 0.00% | – |
Q2 2022 | $7,000 | -12.5% | 115 | 0.0% | 0.00% | – |
Q1 2022 | $8,000 | -20.0% | 115 | 0.0% | 0.00% | – |
Q4 2021 | $10,000 | 0.0% | 115 | 0.0% | 0.00% | – |
Q3 2021 | $10,000 | -9.1% | 115 | 0.0% | 0.00% | – |
Q2 2021 | $11,000 | -15.4% | 115 | 0.0% | 0.00% | – |
Q1 2021 | $13,000 | -13.3% | 115 | +8.5% | 0.00% | – |
Q4 2020 | $15,000 | – | 106 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 441,159 | $39,788,000 | 2.62% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,100 | $9,286,000 | 2.24% |
Rock Springs Capital Management LP | 801,109 | $72,252,000 | 1.52% |
Avidity Partners Management LP | 455,000 | $41,036,000 | 0.91% |
Motley Fool Asset Management LLC | 134,357 | $12,118,000 | 0.79% |
FEDERATED HERMES, INC. | 3,987,032 | $359,590,000 | 0.68% |
EMERALD ADVISERS, LLC | 196,124 | $17,688,000 | 0.64% |
Ergoteles LLC | 128,100 | $11,553,000 | 0.42% |
Tekla Capital Management LLC | 140,726 | $12,692,000 | 0.41% |
Beck Bode, LLC | 14,990 | $1,352,000 | 0.38% |